Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

ClinicalTrials.gov ID: NCT00757588

Public ClinicalTrials.gov record NCT00757588. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Insulin Alone or on Insulin in Combination With Metformin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the effects of saxagliptin with those of placebo as add-on therapy to insulin and insulin with metformin in improving glycemic control at 24 and 52 weeks.

Study identification

NCT ID
NCT00757588
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
455 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 78 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2008 (Type not available)
Primary completion
Apr 2010 (Actual)
Completion
Apr 2010 (Actual)
Last update posted
Jun 1, 2015

2008 – 2010

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
16
Facility City State ZIP Site status
Clinical Research Advantage, Inc Tempe Arizona 85282 —
Valley Research Fresno California 93720 —
Torrance-Lomita Medical Center Lomita California 90717 —
Diabetes Medical Center Of California Northridge California 91325 —
Ritchken & First M.D.'S San Diego California 92117 —
Encompass Clinical Research Spring Valley California 91978 —
Central Florida Clinical Trials, Inc. Altamonte Springs Florida 32701 —
Family Care Associates Of Nw Florida Chipley Florida 32428 —
Panhandle Family Care Assoc. & Coastal Palms Res. Grp Inc. Marianna Florida 32446 —
Endocrine Research Solutions, Inc. Roswell Georgia 30076 —
Danny W. Jackson P.A. Rolling Fork Mississippi 39159 —
Southgate Medical Group West Seneca New York 14224 —
Southeastern Research Associates, Inc. Taylors South Carolina 29687 —
Texas Center For Drug Development Houston Texas 77081 —
Dgd Research, Inc. San Antonio Texas 78229 —
Aurora Advanced Healthcare Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00757588, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00757588 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →